Huai-qiang, H., Yong-hong, Z. & Xin-lu, W. Clinical study on effect of Xiaoyao Nose Drops in stopping episode of Migraine., Chin. J. Integr. Med. 12, 112–117 (2006). https://doi.org/10.1007/BF02857356
Hu Huai-qiang, Zhou Yong-hong, Wang Xin-lu. Clinical study on effect of Xiaoyao Nose Drops in stopping episode of Migraine[J]. Chinese Journal of Integrative Medicine, 2006,12(2):112-117.
Huai-qiang, H., Yong-hong, Z. & Xin-lu, W. Clinical study on effect of Xiaoyao Nose Drops in stopping episode of Migraine., Chin. J. Integr. Med. 12, 112–117 (2006). https://doi.org/10.1007/BF02857356DOI:
Hu Huai-qiang, Zhou Yong-hong, Wang Xin-lu. Clinical study on effect of Xiaoyao Nose Drops in stopping episode of Migraine[J]. Chinese Journal of Integrative Medicine, 2006,12(2):112-117. DOI: 10.1007/BF02857356.
Clinical study on effect of Xiaoyao Nose Drops in stopping episode of Migraine
摘要
Objective: To observe the effect of Xiaoyao Nose Drops (XYND) in stopping episode of migraine.Methods: Adopted was the randomized double-blinded placebo-controled method
with the 126 patients equally assigned to two groups
the treated group treated with XYND and the control group with placebo
and the therapeutic course was 30 days for all. The clinical total effective rate and effect in alleviating headache were observed. And hemorrheological parameters as well as the blood flow of the anterior cerebral artery (ACA)
median cerebral artery (MCA) and posterior cerebral artery (PCA) were measured before and after treatment.Results: The clinical total effective rate and headache alleviating rate in the treated group were 93. 33% and 96. 67% respectively
while those in the control group were 18. 33% and 20.00% respectively
and comparison between the two groups showed significant difference (allP< 0.01). The blood viscosity (high
middle and low shear)
plasma viscosity and fibrinogen got lowered significantly in the treated group after treatment
showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P< 0.05 orP< 0.01). The velocity of blood flow in all cerebral arteries lowered significantly
also showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P< 0.05 orP< 0.01).Conclusion: XYND is effective in stopping the headache of patients with migraine
and worth applying in clinical practice.
Abstract
Objective: To observe the effect of Xiaoyao Nose Drops (XYND) in stopping episode of migraine.Methods: Adopted was the randomized double-blinded placebo-controled method
with the 126 patients equally assigned to two groups
the treated group treated with XYND and the control group with placebo
and the therapeutic course was 30 days for all. The clinical total effective rate and effect in alleviating headache were observed. And hemorrheological parameters as well as the blood flow of the anterior cerebral artery (ACA)
median cerebral artery (MCA) and posterior cerebral artery (PCA) were measured before and after treatment.Results: The clinical total effective rate and headache alleviating rate in the treated group were 93. 33% and 96. 67% respectively
while those in the control group were 18. 33% and 20.00% respectively
and comparison between the two groups showed significant difference (allP< 0.01). The blood viscosity (high
middle and low shear)
plasma viscosity and fibrinogen got lowered significantly in the treated group after treatment
showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P< 0.05 orP< 0.01). The velocity of blood flow in all cerebral arteries lowered significantly
also showing significant difference in comparison either with those before treatment or with those in the control group after treatment (P< 0.05 orP< 0.01).Conclusion: XYND is effective in stopping the headache of patients with migraine
and worth applying in clinical practice.
关键词
Xiaoyao Nose DropsMigrainetransnasal medicationClinical Study
Keywords
Xiaoyao Nose DropsMigrainetransnasal medicationClinical Study
references
Guo SS. Epidemiologic survey on migraine in China. J Chin Neurol 1991; 4(2): 65–69.
The cooperation group of national encephalopathic emergency case of State Administration of Traditional Chinese Medicine. Diagnostic criteria and curative effective evaluated criteria of head wind. J Beijing Univ Chin Med 1993; 16(3): 69.
Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994; 44(Supp17): 8.
Zheng XY, editor. Guiding principle of clinical research on new drugs of TCM (trial). Beijing: Chinese Medico-Pharmaceutical Sciences and Technology Publishing House, 2002: 105–109.
Ni JX. Monitor of alagesic qualification and quantification. In: Li ZL, An JX, Ni JX, et al. editors. Clinical therapeutics on pain. Tianjin: Tianjin Science and Technology Publishing House, 1994: 383–390.
Wang YS. Pharmacology and application of traditional Chinese medicine. Beijing: People’s Medical Publishing House, 1983: 78.
Nie H, Shen YJ, Wu JM, et al. The study of effect of analgesia and sedation and physical dependence of Dahurian Angelica Root volatile oil. Tradit New Chin Drug Res Clin Pharmacol 2002; 13(4): 221–223.
Wang YT, Yang K, Wang JK, et al. Pharmacology of Incised Notoptetygium Rhizome or Root. Pharmacol Clin Chin Materia Medica 1996; 12(4): 12–15.
Jin HT, Wang XD. Migraine and hemorheological changes. J Bengbu Med Coll 1995; 20(3): 168–169.
Guo SS, Xue GB, Wang GQ, et al. Studies of rCBF and TCD in migraine. J Clin Neurol 1995; 8(5): 265–267.